Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-17-020802
Filing Date
2017-04-03
Accepted
2017-04-03 06:18:51
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a17-1485_310ka.htm 10-K/A 686349
2 EX-31.3 a17-1485_3ex31d3.htm EX-31.3 4644
3 EX-31.4 a17-1485_3ex31d4.htm EX-31.4 4451
  Complete submission text file 0001104659-17-020802.txt   696469
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37719 | Film No.: 17732223
SIC: 2834 Pharmaceutical Preparations